GlassScriptPhysician profile
Angela D Rodriguez
NPI 1447998240
$1,368.65
in general payments reported to CMS, 2019-2025
21 companies · $555 in 2025
The $555 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $223 · 2023: $252 · 2024: $339 · 2025: $555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,145.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $258.95 | 2022-2025 | Mounjaro, Zepbound |
| La Jolla Pharmaceutical Company | $154.61 | 2024 | Xerava |
| Abbvie INC. | $139.42 | 2024 | |
| Shionogi INC | $125.01 | 2025 | Fetroja |
| Inari Medical, INC. | $115.05 | 2022 | |
| Kerecis Limited | $110.76 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Astrazeneca Pharmaceuticals LP | $51.65 | 2023-2025 | Farxiga, Airsupra |
| Novo Nordisk INC | $43.11 | 2023-2024 | Ozempic, Rybelsus |
| Organogenesis INC. | $42.70 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $42.02 | 2023-2025 | Nuedexta, Rexulti |
| Novartis Pharmaceuticals Corporation | $38.61 | 2022 | |
| Nevro Corp. | $37.84 | 2023 | Senza |
| Bayer Healthcare Pharmaceuticals INC. | $34.61 | 2023-2025 | |
| Exact Sciences Corporation | $33.31 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Dexcom, INC. | $25.12 | 2025 | Dexcom G6 Transmitter |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $23.14 | 2025 | |
| Purdue Pharma L.P. | $23.08 | 2024 | Nalmefene Hydrochloride |
| Pfizer INC. | $21.05 | 2025 | |
| Axonics, INC. | $18.07 | 2023 | Axonics |
| Janssen Pharmaceuticals, INC | $17.35 | 2023 | Xarelto |
| Astellas Pharma US INC | $13.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.